CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $1,239,000
- in 1 filing
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$1.2M President and CEO 1 filing
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-19 | FORD KATHLEEN Chief Operating Officer | Sale 10b5-1 | −1,558 | $6.28 | $10K | 21,367 |
| 2025-03-21 | Hasnain Faheem Director | Option exercise | +22,682 | $6.32 | $143K | 46,665 |
| 2025-03-21 | Hasnain Faheem Director | Sale | −22,682 | $8.00 | $181K | 23,983 |
| 2025-01-28 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −2,241 | $7.87 | $18K | 90,901 |
| 2025-01-28 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −887 | $7.87 | $7K | 90,014 |
| 2025-01-28 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −699 | $7.87 | $6K | 89,315 |
| 2025-01-28 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −1,122 | $7.87 | $9K | 88,193 |
| 2025-01-28 | Leoni Mollie Chief Medical Officer | Sale | −2,253 | $7.87 | $18K | 90,963 |
| 2025-01-28 | Leoni Mollie Chief Medical Officer | Sale | −1,353 | $7.87 | $11K | 89,610 |
| 2025-01-28 | Leoni Mollie Chief Medical Officer | Sale | −816 | $7.87 | $6K | 88,794 |
| 2025-01-28 | Leoni Mollie Chief Medical Officer | Sale | −541 | $7.87 | $4K | 88,253 |
| 2025-01-28 | Bair Teresa Brophy Chief Legal Officer | Sale | −2,437 | $7.87 | $19K | 112,792 |
| 2025-01-28 | Bair Teresa Brophy Chief Legal Officer | Sale | −4,844 | $7.87 | $38K | 107,948 |
| 2025-01-28 | FORD KATHLEEN Chief Operating Officer | Sale | −1,817 | $7.87 | $14K | 21,367 |
| 2025-01-28 | Burrows Francis Chief Scientific Officer | Sale | −846 | $7.87 | $7K | 22,025 |
| 2025-01-28 | Burrows Francis Chief Scientific Officer | Sale | −1,320 | $7.87 | $10K | 20,705 |
| 2025-01-28 | Powl Brian T. Chief Commercial Officer | Sale | −1,583 | $7.87 | $12K | 59,667 |
| 2025-01-02 | Leoni Mollie Chief Medical Officer | Grant or award | +46,250 | 93,216 | ||
| 2025-01-02 | Leoni Mollie Chief Medical Officer | Grant or award · Option to purchase common stock | +92,500 | 92,500 | ||
| 2025-01-02 | Burrows Francis Chief Scientific Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 |
Page 6 of 9 · 164 trades